Search Results for: sanofi

Agnieszka Grzybowska-Zalewska appointed as new President of the Management Board of Sanofi
|

Agnieszka Grzybowska-Zalewska appointed as new President of the Management Board of Sanofi

Sanofi-Aventis has appointed Agnieszka Grzybowska-Zalewska to the position of CEO. Previously, since 2013, she served as CEO of Sanofi Genzyme in Poland, one of Sanofi’s core business units. Magdalena Kruszewska, previously CEO of Sanofi in Poland, moves to the global structure. Magdalena Kruszewska, who has been promoted to head the newly created Central and Southern…

STADA acquires Sanofi’s consumer healthcare brands & strikes distribution agreement
| |

STADA acquires Sanofi’s consumer healthcare brands & strikes distribution agreement

STADA is embarking on a significant expansion of its European Consumer Healthcare portfolio. The company agreed to acquire from Sanofi portfolio of 16 well-established local and regional consumer healthcare brands in 13 European countries, including Poland. The transaction is scheduled to close in Q3 2021, subject to the approval of relevant regulatory authorities and other customary…

Sanofi poszuka nowych terapii dzięki analizie big data
| |

Sanofi poszuka nowych terapii dzięki analizie big data

Sanofi przeanalizuje big data na temat pacjentów w czasie rzeczywistym Firma farmaceutyczna Sanofi i Google zawarły porozumienie o współpracy. Celem być ma znalezienie przez potentata farmaceutycznego nowych kierunków rozwoju w kontekście opracowywania nowych leków. Firmy stworzą wspólny InnovationHub, dzięki któremu analizowane będą tzw. big data, czyli duże zbiory danych pochodzące z internetu. Dane te będą…

Instagram: Sanofi is a pioneer in the industry
| |

Instagram: Sanofi is a pioneer in the industry

In mid-October, Sanofi Polska launched Instagram social network account. This is the first pharmaceutical company in Poland to take such a step.  Will others follow in its footsteps? Sanofi has already had accounts on other portals, such as LinkedIn and Twitter. Within LinkedIn the company builds its image as a desired employer, she explained with an…

Israel’s promising COVID drug successfully passes II Phase of research
| |

Israel’s promising COVID drug successfully passes II Phase of research

Israel’s Covid drug EXO-CD24, subjected to Phase II trials in Athens, allowed 29 out of 30 moderate to severe patients to recover in up to 5 days. The Phase II trial confirmed the results of Phase I, conducted in Israel last winter. About 93% of 90 patients with severe COVID-19 were treated with the novel Israeli medication produced…

COVID-19: Pfizer and BioNTech vaccine – is it a breakthrough?

COVID-19: Pfizer and BioNTech vaccine – is it a breakthrough?

On Monday, Pfizer and BioNTech reported that the COVID-19 vaccine they are working on is over 90% effective. At that time, the world was overwhelmed with enthusiasm. On Wednesday, the EC signed an agreement with these companies to purchase 300 million doses of vaccine. So can we expect the pandemic to end soon? Pfizer and…

Perrigo invests in the Nepentes portfolio

Perrigo invests in the Nepentes portfolio

The Office of Competition and Consumer Protection has received an application for a permit to acquire some of the products belonging to the portfolio of Nepentes Pharma Sp. z o.o., part of the Sanofi group. Under the concentration, Perrigo will become their owner. Portfolio expanded by key brands The acquisition concerns three of Sanofi’s key…

AstraZeneca: contract for 400 million doses of COVID-19 vaccine with EC

AstraZeneca: contract for 400 million doses of COVID-19 vaccine with EC

The European Commission (EC) announced at the end of last week that it had signed a contract to purchase 400 million doses of COVID-19 vaccine. The contract was signed with AstraZeneca. The value of the contract has not been disclosed. It is only known that the EC paid an advance of EUR 336m. Vaccine purchase…

Expensive merger in the pharmaceutical industry

Expensive merger in the pharmaceutical industry

Johnson & Johnson announced that it has entered into an agreement to purchase Momenta Pharmaceuticals, a manufacturer of drugs for autoimmune diseases. This is one of the largest transaction on the pharmaceutical market this year. Finalisation of the transaction in 2020 Under the terms of the transaction, which have been approved by the boards of…